ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.07%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,649.87
0.00%
Brent Oil
71.98
-0.08%
Bitcoin
96,728.73
-0.78%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) News

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCRX
DateTimeSourceHeadlineSymbolCompany
14/11/202415:05GlobeNewswire Inc.Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
12/11/202413:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare ConferencesNASDAQ:PCRXPacira BioSciences Inc
06/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
06/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
06/11/202421:00GlobeNewswire Inc.Pacira BioSciences Reports Third Quarter 2024 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
05/11/202421:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
04/11/202413:00GlobeNewswire Inc.Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient SettingsNASDAQ:PCRXPacira BioSciences Inc
30/10/202412:00GlobeNewswire Inc.Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024NASDAQ:PCRXPacira BioSciences Inc
23/10/202422:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
21/10/202412:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
21/10/202412:00GlobeNewswire Inc.Pacira BioSciences Appoints Shawn Cross as Chief Financial OfficerNASDAQ:PCRXPacira BioSciences Inc
07/10/202412:00GlobeNewswire Inc.Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PCRXPacira BioSciences Inc
03/10/202412:00GlobeNewswire Inc.Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025NASDAQ:PCRXPacira BioSciences Inc
27/09/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
26/09/202412:00GlobeNewswire Inc.Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
25/09/202412:15PR Newswire (US)DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to ShareholdersNASDAQ:PCRXPacira BioSciences Inc
14/09/202400:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
13/09/202414:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
09/09/202420:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
09/09/202420:00GlobeNewswire Inc.Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PCRXPacira BioSciences Inc
19/08/202412:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
14/08/202420:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
13/08/202420:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
13/08/202412:43Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PCRXPacira BioSciences Inc
13/08/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
13/08/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
09/08/202419:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
09/08/202419:21GlobeNewswire Inc.Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New JerseyNASDAQ:PCRXPacira BioSciences Inc
02/08/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
02/08/202414:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:PCRX

Your Recent History

LSE
SYME
Supply@me Capital
LSE
POS
Plexus
LSE
VRS
Versarien
LSE
GOLD
LSE
ZED
Zenova
LSE
QBT
Quantum Blockchain Techn...
LSE
VAST
Vast Resources
LSE
SRSP
Sirius Petroleum
LSE
BOO
Boohoo
LSE
AV.
Aviva
LSE
NFDS
Northern Foods
LSE
SFR
Severfield
LSE
CHLL
Chill Brands
LSE
BGEO
Bank Of Georgia
LSE
GFM
Griffin Mining
LSE
SCE
Surface Transforms
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Level 2 Lite

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £2132.64 only 1066.32